» Articles » PMID: 20515211

Depression, Craving, and Substance Use Following a Randomized Trial of Mindfulness-based Relapse Prevention

Overview
Specialty Psychology
Date 2010 Jun 3
PMID 20515211
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: A strong relation between negative affect and craving has been demonstrated in laboratory and clinical studies, with depressive symptomatology showing particularly strong links to craving and substance abuse relapse. Mindfulness-based relapse prevention (MBRP), shown to be efficacious for reduction of substance use, uses mindfulness-based practices to teach alternative responses to emotional discomfort and lessen the conditioned response of craving in the presence of depressive symptoms. The goal in the current study was to examine the relation between measures of depressive symptoms, craving, and substance use following MBRP.

Method: Individuals with substance use disorders (N = 168; mean age 40.45 years, SD = 10.28; 36.3% female; 46.4% non-White) were recruited after intensive stabilization, then randomly assigned to either 8 weekly sessions of MBRP or a treatment-as-usual control group. Approximately 73% of the sample was retained at the final 4-month follow-up assessment.

Results: Results confirmed a moderated-mediation effect, whereby craving mediated the relation between depressive symptoms (Beck Depression Inventory) and substance use (Timeline Follow-Back) among the treatment-as-usual group but not among MBRP participants. MBRP attenuated the relation between postintervention depressive symptoms and craving (Penn Alcohol Craving Scale) 2 months following the intervention (f(2) = .21). This moderation effect predicted substance use 4 months following the intervention (f(2) = .18).

Conclusion: MBRP appears to influence cognitive and behavioral responses to depressive symptoms, partially explaining reductions in postintervention substance use among the MBRP group. Although results are preliminary, the current study provides evidence for the value of incorporating mindfulness practice into substance abuse treatment and identifies a potential mechanism of change following MBRP.

Citing Articles

A pilot study of twice-weekly group-based written exposure therapy for veterans in residential substance use treatment: effects on PTSD and depressive symptoms.

Van Doren N, Chang F, Nguyen A, McKenna K, Satre D, Wiltsey-Stirman S Addict Sci Clin Pract. 2025; 20(1):11.

PMID: 39924479 PMC: 11809123. DOI: 10.1186/s13722-024-00531-0.


Mindfulness Training vs Recovery Support for Opioid Use, Craving, and Anxiety During Buprenorphine Treatment: A Randomized Clinical Trial.

Schuman-Olivier Z, Goodman H, Rosansky J, Fredericksen A, Barria J, Parry G JAMA Netw Open. 2025; 8(1):e2454950.

PMID: 39836426 PMC: 11751747. DOI: 10.1001/jamanetworkopen.2024.54950.


Within-person affect dynamics among individuals in residential treatment for opioid use disorder: An ecological momentary assessment study.

Knapp K, Petrie D, Brick T, Deneke E, Bunce S, Cleveland H J Psychopathol Clin Sci. 2025; 134(2):184-200.

PMID: 39786821 PMC: 11835537. DOI: 10.1037/abn0000975.


A Pilot Study of Twice-Weekly Group-Based Written Exposure Therapy for Veterans in Residential Substance Use Treatment: Effects on PTSD and Depressive Symptoms.

Doren N, Chang F, Nguyen A, McKenna K, Satre D, Wiltsey-Stirman S Res Sq. 2024; .

PMID: 39070612 PMC: 11275991. DOI: 10.21203/rs.3.rs-4511374/v1.


The methods and baseline characteristics of a multi-site randomized controlled trial evaluating mindfulness-based relapse prevention in conjunction with peer support to improve adherence to medications for opioid use disorders.

Mumba M, Mugoya G, Allen R, Glenn A, Richman J, Ghera A Front Psychiatry. 2024; 15:1330672.

PMID: 38974917 PMC: 11224476. DOI: 10.3389/fpsyt.2024.1330672.


References
1.
Weiss F, Markou A, Lorang M, Koob G . Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 1992; 593(2):314-8. DOI: 10.1016/0006-8993(92)91327-b. View

2.
Chawla N, Collin S, Bowen S, Hsu S, Grow J, Douglass A . The mindfulness-based relapse prevention adherence and competence scale: development, interrater reliability, and validity. Psychother Res. 2010; 20(4):388-97. PMC: 3280680. DOI: 10.1080/10503300903544257. View

3.
Shiffman S, Gwaltney C, Balabanis M, Liu K, Paty J, Kassel J . Immediate antecedents of cigarette smoking: an analysis from ecological momentary assessment. J Abnorm Psychol. 2002; 111(4):531-45. DOI: 10.1037//0021-843x.111.4.531. View

4.
Zilberman M, Tavares H, Hodgins D, El-Guebaly N . The impact of gender, depression, and personality on craving. J Addict Dis. 2007; 26(1):79-84. DOI: 10.1300/J069v26n01_10. View

5.
Koob G, Bloom F . Cellular and molecular mechanisms of drug dependence. Science. 1988; 242(4879):715-23. DOI: 10.1126/science.2903550. View